AZBIX | VSCIX | AZBIX / VSCIX | |
Total Expense Ratio | 1.09 | 0.04 | 2,725% |
Annual Report Gross Expense Ratio | 1.27 | 0.04 | 3,175% |
Fund Existence | 12 years | 28 years | - |
Gain YTD | 0.000 | 2.806 | - |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 96.3M | 153B | 0% |
Annual Yield % from dividends | 0.66 | 1.41 | 47% |
Returns for 1 year | -3.19 | 8.49 | -38% |
Returns for 3 years | 18.67 | 34.26 | 54% |
Returns for 5 years | 31.43 | 66.87 | 47% |
Returns for 10 years | 33.73 | 115.25 | 29% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ISOPX | 17.49 | 0.17 | +0.98% |
Voya SmallCap Opportunities Port A | |||
SBHIX | 23.33 | 0.12 | +0.52% |
Saratoga Health & Biotechnology I | |||
ISTIX | 84.29 | 0.34 | +0.41% |
Macquarie Science and Technology I | |||
IBNAX | 25.13 | 0.09 | +0.36% |
Macquarie Balanced Fund Class A | |||
AILLX | 28.11 | 0.07 | +0.25% |
Aristotle Core Equity I-2 |